Argenx Se (ARGX) Cash & Equivalents (2015 - 2026)
Argenx Se (ARGX) posted Cash & Equivalents of $3.58 billion for Q2 2026, up 71.8% from $2.09 billion a year earlier.
Powered by 
Analysis
Argenx Se (ARGX) Cash & Equivalents (2015 - 2026) Analysis & Trends
At the end of FY2025, Argenx Se's Cash & Equivalents came in at $3.49 billion, up 132.7% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 23.5% (FY2020 to FY2025).
- In prior years, Argenx Se's Cash & Equivalents was $1.5 billion in FY2024 (-26.8%), $2.05 billion in FY2023 (+155.9%), $800.74 million in FY2022 (-40.0%) and $1.33 billion in FY2021 (+9.7%).
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents in data going back to Q4 2015.
- On a year-over-year basis, Cash & Equivalents increased in three of the last four quarters, with growth averaging 55.7%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2023, with growth of 155.9%; the weakest was Q4 2022, with a decline of 40.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Argenx Se | 56.96 Bn | 56.96 Bn | 1.56 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.58 Bn |
| Dec 31, 2025 | 3.49 Bn |
| Jun 30, 2025 | 2.09 Bn |
| Dec 31, 2024 | 1.50 Bn |
| Jun 30, 2024 | 1.44 Bn |
| Dec 31, 2023 | 2.05 Bn |
| Jun 30, 2023 | 1.11 Bn |
| Dec 31, 2022 | 800.74 Mn |
| Jun 30, 2022 | 1.37 Bn |
| Dec 31, 2021 | 1.33 Bn |
| Jun 30, 2021 | 1.58 Bn |
| Dec 31, 2020 | 1.22 Bn |
| Jun 30, 2020 | 1.35 Bn |
| Dec 31, 2019 | 371.11 Mn |
| Jun 30, 2019 | 190.83 Mn |
| Dec 31, 2018 | 321.51 Mn |
| Jun 30, 2018 | 162.89 Mn |
| Dec 31, 2017 | 227.93 Mn |
| Jun 30, 2017 | 86.42 Mn |
| Dec 31, 2016 | 95.07 Mn |
API Access
Argenx Se Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ARGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ARGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ARGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();